dabigatranetexilate相关论文
Does novel oral anticoagulant improve anticoagulation for non-valvular atrial fibrillation associate
...
心房颤动所致脑卒中的致残率和病死率高。和华法林相比，新型口服抗凝药物达比加群酯已被证明预防心房颤动的脑卒中和栓塞安全有效，无......
达比加群酯作为非瓣膜心房颤动抗凝治疗新型口服抗凝药,其抗凝作用与华法林相当,出血风险较华法林减少约20%,较华法林具有诸多优势......
